Intensity Therapeutics Reports INVINCIBLE-4, Presurgical Triple-Negative Breast Cancer Study Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/30/2026

1. NTAP
2. SPY
3. NVDA
4. MDB
5. FFAI
6. MTN
7. META
8. AIR
9. ORCL
10. SPCX

Go back to Intensity Therapeutics Reports INVINCIBLE-4, Presurgical Triple-Negative Breast Cancer Study Update
(NASDAQ: INTS) Delayed: 3.42 -0.23 (6.3%)
Previous Close $3.65    52 Week High $ 
Open $3.70    52 Week Low $ 
Day High $3.70    P/E N/A 
Day Low $3.27    EPS $ 
Volume 34,071